drugset / Trial / NCT05303324
Study of Oral ALXN1840 at 2 Dose Strengths in Healthy Adults
RandomizedCrossoverOpen-labelBasic science
Summary
To assess the relative bioavailability of ALXN1840 administered orally as a single enteric-coated (EC) tablet (reference, Treatment A) versus three EC tablets (test, Treatment B).
Timeline
- Start
- 2019-07-04
- Primary completion
- 2019-10-09
- Completion
- 2019-10-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TIOMOLIBDATE CHOLINE | Small molecule | — | Oral |
Indications
No indication recorded.